![Patrick Nef](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick Nef
Amministratore Delegato presso Transcure Bioservices SAS
Posizioni attive di Patrick Nef
Società | Posizione | Inizio | Fine |
---|---|---|---|
Transcure Bioservices SAS
![]() Transcure Bioservices SAS Miscellaneous Commercial ServicesCommercial Services Transcure Bioservices SAS provides research and development platforms service. It offer services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling and development. The company was founded on June 07, 2012 and is headquartered in Archamps, France. | Amministratore Delegato | 01/01/2012 | - |
Fondatore | 01/01/2012 | - |
Storia della carriera di Patrick Nef
Precedenti posizioni note di Patrick Nef
Società | Posizione | Inizio | Fine |
---|---|---|---|
Domain Therapeutics SA
![]() Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Presidente | 01/01/2005 | 02/01/2005 |
Statistiche
Distribuzione geografica
Francia | 3 |
Posizioni
President | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Settori
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Domain Therapeutics SA
![]() Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
Transcure Bioservices SAS
![]() Transcure Bioservices SAS Miscellaneous Commercial ServicesCommercial Services Transcure Bioservices SAS provides research and development platforms service. It offer services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling and development. The company was founded on June 07, 2012 and is headquartered in Archamps, France. | Commercial Services |
- Borsa valori
- Insiders
- Patrick Nef
- Esperienza